Lendormin D® Tablet (Drug Use Result Survey)

NCT02224014 · clinicaltrials.gov ↗
COMPLETED
Status
485
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Boehringer Ingelheim